EBS

Emergent BioSolutions Inc. Common Stock (EBS)

Stock · NYSE · Health Care

$5.91as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$7.93
Industry
Biotechnology: Pharmaceutical Preparations

How Emergent BioSolutions Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$742.90MNet Income$52.60M (7%)Cost of Revenue$326.20M (44%)SG&A$186.10M (25%)Other$94.60M (13%)R&D$53.20M (7%)Tax$30.20M (4%)EBS

Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub

Emergent BioSolutions Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • EBS
    Emergent BioSolutions Inc. Common Stock
    $5.91
    ▼ 0.51%
    Market cap $382.33MP/E
  • ENTA
    Enanta Pharmaceuticals Inc. Common Stock
    $13.6
    ▼ 1.45%
    Market cap $376.57MP/E
    $7.05$17.15
  • PBYI
    Puma Biotechnology Inc Common Stock
    $9.07
    ▼ 1.89%
    Market cap $391.42MP/E 18.65
    $4.3$9.51
  • RCKT
    Rocket Pharmaceuticals Inc. Common Stock
    $3.86
    ▲ 6.49%
    Market cap $372.35MP/E
    $2.53$5.45
  • EOLS
    Evolus Inc. Common Stock
    $8.89
    ▲ 0.06%
    Market cap $398.42MP/E
    $3.86$9.12
  • DMAC
    DiaMedica Therapeutics Inc. Common Stock
    $6.39
    ▼ 5.33%
    Market cap $351.32MP/E
    $5.14$10.42
  • LRMR
    Larimar Therapeutics Inc. Common Stock
    $4
    ▼ 1.23%
    Market cap $413.45MP/E
    $2.72$6.42

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
41.40M
Total value held
$321.76M
Institutional holders
185
Top holders this quarter
  • Unknown4.34M
  • Unknown2.85M
  • Unknown2.76M
  • Unknown2.43M
  • Unknown2.26M
  • Unknown1.51M
  • Unknown1.38M
  • Unknown1.27M
  • Unknown1.20M
  • Unknown1.11M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.